Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Renske M. Van den Berg‐Vos"'
Autor:
Inger A. Deijle, Roelofjan Hemmes, H. Myrthe Boss, Edwin C. de Melker, Bob T. J. van den Berg, Gert Kwakkel, Erwin van Wegen, Wendy M. Bosboom, Henry C. Weinstein, Sander M. van Schaik, Renske M. Van den Berg-Vos
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Patients with a transient ischemic attack (TIA) or ischemic stroke are at increased risk of developing cognitive impairment in the subacute phase. At present, the effects of exercise on cognitive functioning following a TIA or str
Externí odkaz:
https://doaj.org/article/6c61652ca406424d911c0d6014e3294a
Autor:
Valentijn J. Zonjee, Jos P. L. Slenders, Frank de Beer, Marieke C. Visser, Bastiaan C. ter Meulen, Renske M. Van den Berg-Vos, Sander M. van Schaik
Publikováno v:
BMC Medical Ethics, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Obtaining informed consent for intravenous thrombolysis in acute ischemic stroke can be challenging, and little is known about if and how the informed consent procedure is performed by neurologists in clinical practice. This study
Externí odkaz:
https://doaj.org/article/2cbbb76345f04150a107181ca244392d
Publikováno v:
Brain Sciences, Vol 13, Iss 4, p 561 (2023)
Fatigue is a common complaint and a disabling symptom among patients following transient ischemic attack (TIA) or minor stroke. In patients with stroke, decreased cardiorespiratory fitness (CRF) is believed to be related to increased severity of post
Externí odkaz:
https://doaj.org/article/ac51b31ddab349ff9ce93660f1895cbf
Autor:
Laurien S. Kuhrij, Perla J. Marang-van de Mheen, Renske M. van den Berg-Vos, Frank-Erik de Leeuw, Paul J. Nederkoorn, on behalf of the Dutch Acute Stroke Audit consortium
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Intravenous thrombolysis (IVT) plays a prominent role in the treatment of acute ischemic stroke (AIS). The sooner IVT is administered, the higher the odds of a good outcome. Therefore, registering the in-hospital time to treatment
Externí odkaz:
https://doaj.org/article/61b4502873454ead821b01ced5dd92da
Autor:
Sander M. Van Schaik, Saskia Scott, Lonneke M.L. de Lau, Renske M. Van den Berg-Vos, Nyika D. Kruyt
Publikováno v:
Cerebrovascular Diseases Extra, Vol 5, Iss 2, Pp 75-83 (2015)
Background: The clinical benefit of intravenous thrombolysis (IVT) in acute ischemic stroke is time dependent. Several studies report a short median door-to-needle time (DNT; 20 min), mainly in large tertiary referral hospitals equipped with a level
Externí odkaz:
https://doaj.org/article/5e485f8b0bbe4df7a6f8dcc354fc5166
Autor:
H. Myrthe Boss, Yolanda van der Graaf, Frank L. J. Visseren, Renske M. Van den Berg‐Vos, Michiel L. Bots, Gert Jan de Borst, Maarten J. Cramer, L. Jaap Kappelle, Mirjam I. Geerlings
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 7 (2017)
BackgroundPhysical activity reduces the risk of vascular disease. This benefit is not entirely explained through an effect on vascular risk factors. We examined the relationship of physical activity and characteristics of the carotid artery wall in p
Externí odkaz:
https://doaj.org/article/2cbb236a31454965a2eaa338791384cb
Autor:
Jos P.L. Slenders, Joris A. de Graaf, Marcel W.M. Post, Caroline M. van Heugten, Renske M. Van den Berg-Vos, Vincent I.H. Kwa, Johanna M.A. Visser-Meily
Publikováno v:
Topics in Stroke Rehabilitation. Thomas Land Publishers Inc.
Background: After stroke, many patients experience problems with participation in daily activities. Improving participation is the main goal in stroke rehabilitation. However, the longitudinal relationship between participation and health-related qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5fb7e54d10783298535a96ae528dde
https://cris.maastrichtuniversity.nl/en/publications/99718997-3a04-4b6a-adde-e1dd62c6d46f
https://cris.maastrichtuniversity.nl/en/publications/99718997-3a04-4b6a-adde-e1dd62c6d46f
Autor:
Nadinda A.M. van der Ende, Bob Roozenbeek, Olvert A. Berkhemer, Peter J. Koudstaal, Jelis Boiten, Ewoud J. van Dijk, Yvo B.W.E.M. Roos, Robert J. van Oostenbrugge, Charles B.L.M. Majoie, Wim van Zwam, Hester F. Lingsma, Aad van der Lugt, Diederik W.J. Dippel, Puck S.S. Fransen, Debbie Beumer, Lucie A. van den Berg, Albert J. Yoo, Wouter J. Schonewille, Jan Albert Vos, Paul J. Nederkoorn, Marieke J.H. Wermer, Marianne A.A. van Walderveen, Julie Staals, Jeannette Hofmeijer, Jacques A. van Oostayen, Geert J. Lycklama a Nijeholt, Patrick A. Brouwer, Bart J. Emmer, Sebastiaan F. de Bruijn, Lukas C. van Dijk, L. Jaap Kappelle, Rob H. Lo, Joost de Vries, Paul L.M. de Kort, Willem Jan J. van Rooij, Jan S.P. van den Berg, Boudewijn A.A.M. van Hasselt, Leo A.M. Aerden, Rene J. Dallinga, Marieke C. Visser, Joseph C.J. Bot, Patrick C. Vroomen, Omid Eshghi, Tobien H.C.M.L. Schreuder, Roel J.J. Heijboer, Koos Keizer, Alexander V. Tielbeek, Heleen M. den Hertog, Dick G. Gerrits, Renske M. van den Berg-Vos, Giorgos B. Karas, Ewout W. Steyerberg, H. Zwenneke Flach, Henk A. Marquering, Marieke E.S. Sprengers, Sjoerd F.M. Jenniskens, Ludo F.M. Beenen, Rene van den Berg
Publikováno v:
Stroke, 53(1), 61-69. LIPPINCOTT WILLIAMS & WILKINS
Stroke, 53(1), 61-69. Lippincott Williams and Wilkins
Stroke, 53, 61-69
Stroke
Stroke, 53(1), 61-69. Lippincott Williams & Wilkins
Stroke, 53, 1, pp. 61-69
Stroke, 53(1), 61-69. Lippincott Williams and Wilkins
Stroke, 53, 61-69
Stroke
Stroke, 53(1), 61-69. Lippincott Williams & Wilkins
Stroke, 53, 1, pp. 61-69
Supplemental Digital Content is available in the text.
Background and Purpose: Blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging. Unblinding can result in misclassified outcomes and bia
Background and Purpose: Blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging. Unblinding can result in misclassified outcomes and bia
Autor:
René Post, Menno R Germans, Maud A Tjerkstra, Mervyn D I Vergouwen, Korné Jellema, Radboud W Koot, Nyika D Kruyt, Peter W A Willems, Jasper F C Wolfs, Frits C de Beer, Hans Kieft, Dharmin Nanda, Bram van der Pol, Gerwin Roks, Frank de Beer, Patricia H A Halkes, Loes J A Reichman, Paul J A M Brouwers, Renske M van den Berg-Vos, Vincent I H Kwa, Taco C van der Ree, Irene Bronner, Janneke van de Vlekkert, Henri P Bienfait, Hieronymus D Boogaarts, Catharina J M Klijn, René van den Berg, Bert A Coert, Janneke Horn, Charles B L M Majoie, Gabriël J E Rinkel, Yvo B W E M Roos, W Peter Vandertop, Dagmar Verbaan, Menno R. Germans, Maud A. Tjerkstra, Mervyn D.I. Vergouwen, Radboud W. Koot, Nyika D. Kruyt, Peter W.A. Willems, Jasper F.C. Wolfs, Frits C. de Beer, Patricia H.A. Halkes, Loes J.A. Reichman, Paul J.A.M. Brouwers, Renske M. van den Berg-Vos, Vincent I.H. Kwa, Taco C. van der Ree, Henri P. Bienfait, Hieronymus D. Boogaarts, Catharina J.M. Klijn, Martine van Bilzen, H.J.G. Dieks, Koen de Gans, J.B.M. ten Holter, Jelle R. de Kruijk, Charlie T.J.M. Leijzer, Delmar Molenaar, Robbert J. van Oostenbrugge, Jeske van Pamelen, Fianne H.M. Spaander, Sarah E. Vermeer, J. Manuela Voorend, Bert A. Coert, Charles B.L.M. Majoie, Gabriël J.E. Rinkel, Yvo B.W.E.M. Roos, W. Peter Vandertop
Publikováno v:
Lancet, 397(10269), 112-118. Elsevier Limited
The Lancet (London), 397, 10269, pp. 112-118
ULTRA Investigators 2021, ' Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA) : a randomised controlled trial ', Lancet, vol. 397, no. 10269, pp. 112-118 . https://doi.org/10.1016/S0140-6736(20)32518-6
The Lancet (London), 397, 112-118
The Lancet, 397(10269), 112-118. ELSEVIER SCIENCE INC
The Lancet (London), 397, 10269, pp. 112-118
ULTRA Investigators 2021, ' Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA) : a randomised controlled trial ', Lancet, vol. 397, no. 10269, pp. 112-118 . https://doi.org/10.1016/S0140-6736(20)32518-6
The Lancet (London), 397, 112-118
The Lancet, 397(10269), 112-118. ELSEVIER SCIENCE INC
BACKGROUND: In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding. However, whether this treatment improves clinical outcome is unclear. We inves
Autor:
Paul J. Nederkoorn, Sanne J. den Hartog, Bob Roozenbeek, Renske M. Van den Berg-Vos, Cosette Cornelis, Carla M Bastemeijer
Publikováno v:
Stroke, 52(7), 2432-2435. Lippincott Williams and Wilkins
Stroke, 52(7), 2432-2435. Lippincott Williams & Wilkins
Stroke, 52(7), 2432-2435. Lippincott Williams & Wilkins
Background and Purpose: Patient-reported experience measures (PREMs) assess patients’ perception of health care. We aimed to identify all reported PREMs for stroke care and critically appraise psychometric properties of PREMs validated for patients